Company intelligence / Profile preview

Schaper & Brümmer

Salzgitter-Ringelheim, Lower Saxony, Germanyschaper-bruemmer.com ↗

Ownership: Private
Employees: ~140
Development stage: Commercial

Overview

Schaper & Brümmer develops, manufactures, and markets non-prescription, plant-based pharmaceuticals with decades of experience in phytotherapy. Their products are available in over forty countries. The company invests significantly in R&D focused on optimizing existing compounds and expanding scientific understanding of medicinal plants. Several clinical trials have been completed for their key products such as Esberitox® COMPACT and Remifemin® FeuchtCreme.

Therapeutic areas: Women's HealthImmunologyInfectious Diseases
Modalities: Herbal medicines / phytopharmaceuticalsPlant extracts
Industry: Biotech

Drug pipeline

1 asset

cimicifuga racemosa

Beyond the preview

Go deeper on Schaper & Brümmer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schaper & Brümmer.

Explore the full profile